Metraipolis › archive › dc_ffb53fc08d40

Personalized 3D-Printed Affinisol-Based Pharmaceutical Delivery Systems: The Case Study for Alternative Sulfonamides for Alzheimer's Disease — Europe PMC PMID:42791497

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42791497
DOI: 10.1002/mabi.70266
License (as archived): solo-consultazione
Archived: 2026-10-16T07:59:05.436Z
SHA-256 of the archived text: 0fb4f3dad53f5ffc36e8611b9c297a7ece665c3699341ff59a62303ae33761cb
Stable URL of this page: https://metraipolis.com/documento/dc_ffb53fc08d40

How to cite

Personalized 3D-Printed Affinisol-Based Pharmaceutical Delivery Systems: The Case Study for Alternative Sulfonamides for Alzheimer's Disease — Europe PMC PMID:42791497 — Europe PMC (en), https://europepmc.org/article/MED/42791497 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffb53fc08d40 (Metraipolis archive dc_ffb53fc08d40, sha256 0fb4f3dad53f5ffc36e8611b9c297a7ece665c3699341ff59a62303ae33761cb)

BibTeX

@misc{dcffb53fc08d40,
  title = {Personalized 3D-Printed Affinisol-Based Pharmaceutical Delivery Systems: The Case Study for Alternative Sulfonamides for Alzheimer's Disease — Europe PMC PMID:42791497},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42791497},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffb53fc08d40; sha256 0fb4f3dad53f5ffc36e8611b9c297a7ece665c3699341ff59a62303ae33761cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42791497. Agents can read the archived copy with the MCP tool read_document.